---
title: AustinPx vs Novick Biosciences
slug_a: austinpx
slug_b: novickbio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/austinpx/novickbio
generated_by: BioBM Editorial AI
---

# AustinPx vs Novick Biosciences

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

AustinPx (austinpx) is listed for cdmo. Fee-for-service CDMO specializing in formulation development, process development, and GMP manufacturing of oral dosage forms from preclinical through Phase II, with proprietary KinetiSol amorphous solid dispersion technology for poorly soluble APIs.

Services: 7. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Novick Biosciences (novickbio) is listed for both. Overview Novick Biosciences describes itself as a strategic research partner for pharmaceutical companies, with a stated focus on flexible, innovative, and problem-solving models.

Services: 6. Modalities: 1. Indications: 0. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.